Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD

Respiratory Research

Volumn 12, Issue 1, 2011, Pages

  Löfdahl, Magnus ^a   Kaarteenaho, Riitta ^b   Lappi Blanco, Elisa ^c   Tornling, Göran ^a   Sköld, Magnus C ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DESMIN; TENASCIN; VIMENTIN; ACTA2 PROTEIN, HUMAN; ACTIN;

ADULT; AIRWAY; ARTICLE; BRONCHOSCOPY; BRONCHUS BIOPSY; CELL COUNT; CELLULAR DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOKING; SPINDLE CELL; UPREGULATION; VITAL CAPACITY; ANALYSIS OF VARIANCE; BIOPSY; BRONCHUS; CASE CONTROL STUDY; CHEMISTRY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA; RISK; SWEDEN;

ACTINS; ADULT; ANALYSIS OF VARIANCE; BIOPSY; BRONCHI; BRONCHOSCOPY; CASE-CONTROL STUDIES; DESMIN; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; SMOKING; SWEDEN; TENASCIN; UP-REGULATION; VIMENTIN; VITAL CAPACITY;

EID: 79955091923     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-48     Document Type: Article

References (44)

1. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
2. Lindberg A, Bjerg A, Ronmark E, Larsson LG, Lundback B: Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006, 100:264-272.
3. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E: International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750.
4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [ http://www.goldcopd.com/GuidelinesResources.asp ]
5. Di Stefano A, Caramori G, Ricciardolo FL, Capelli A, Adcock IM, Donner CF: Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy 2004, 34:1156-1167.
6. O'Donnell R, Breen D, Wilson S, Djukanovic R: Inflammatory cells in the airways in COPD. Thorax 2006, 61:448-454.
7. Sullivan AK, Simonian PL, Falta MT, Mitchell JD, Cosgrove GP, Brown KK, Kotzin BL, Voelkel NF, Fontenot AP: Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005, 172:590-596.
8. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G, Bousquet J: Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997, 156:591-599.
9. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653.
10. Roche WR, Beasley R, Williams JH, Holgate ST: Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520-524.
11. Bourdin A, Neveu D, Vachier I, Paganin F, Godard P, Chanez P: Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 2007, 119:1367-1374.
12. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, Hamid Q: Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997, 17:326-333.
13. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D: Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997, 111:852-857.
14. Jeffery PK: Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004, 1:176-183.
15. Liesker JJ, Ten Hacken NH, Zeinstra-Smith M, Rutgers SR, Postma DS, Timens W: Reticular basement membrane in asthma and COPD: similar thickness, yet different composition. Int J Chron Obstruct Pulmon Dis 2009, 4:127-135.
16. Roberts CR, Burke AK: Remodelling of the extracellular matrix in asthma: proteoglycan synthesis and degradation. Can Respir J 1998, 5:48-50.
17. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA: Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997, 156:951-958.
18. Soini Y, Paakko P, Nuorva K, Kamel D, Linnala A, Virtanen I, Lehto VP: Tenascin immunoreactivity in lung tumors. Am J Clin Pathol 1993, 100:145-150.
19. Kaarteenaho-Wiik R, Sademies O, Paakko P, Risteli J, Soini Y: Extracellular matrix proteins and myofibroblasts in granulomas of sarcoidosis, atypical mycobacteriosis, and tuberculosis of the lung. Hum Pathol 2007, 38:147-153.
20. Kaarteenaho R, Sormunen R, Paakko P: Variable expression of tenascin-C, osteopontin and fibronectin in inflammatory myofibroblastic tumour of the lung. APMIS 2010, 118:91-100.
21. Calverley P, Pauwels Dagger R, Lofdahl CG, Svensson K, Higenbottam T, Carlsson LG, Stahl E: Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 2005, 26:406-413.
22. Paakko P, Kaarteenaho-Wiik R, Pollanen R, Soini Y: Tenascin mRNA expression at the foci of recent injury in usual interstitial pneumonia. Am J Respir Crit Care Med 2000, 161:967-972.
23. Kaarteenaho-Wiik R, Kinnula V, Herva R, Paakko P, Pollanen R, Soini Y: Distribution and mRNA expression of tenascin-C in developing human lung. Am J Respir Cell Mol Biol 2001, 25:341-346.
24. Gabbiani G, Ryan GB, Majne G: Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971, 27:549-550.
25. Schurch W, Seemayer TA, Gabbiani G: The myofibroblast: a quarter century after its discovery. Am J Surg Pathol 1998, 22:141-147.
26. Kawka DW, Kazazis DM, Clark RA: In vivo co-distribution of fibronectin and actin fibers in granulation tissue: immunofluorescence and electron microscope studies of the fibronexus at the myofibroblast surface. J Cell Biol 1984, 98:2091-2106.
27. Vancheri C, Failla M, Crimi N, Raghu G: Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 2010, 35:496-504.
28. Chaponnier C, Gabbiani G: Pathological situations characterized by altered actin isoform expression. J Pathol 2004, 204:386-395.
29. Wick MR, Hormnick JL: Immunohistology of soft tissue and osseous neoplasms. In Diagnostic Immunohistochemistry. 3rd edition. Edited by: Dabbs DJ. Saunders Elsevier; 2010:84.
30. Dellagi K, Brouet JC: Redistribution of intermediate filaments during capping of lymphocyte surface molecules. Nature 1982, 298:284-286.
31. Kranenburg AR, Willems-Widyastuti A, Moori WJ, Sterk PJ, Alagappan VK, de Boer WI, Sharma HS: Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease. Am J Clin Pathol 2006, 126:725-735.
32. Gosselink JV, Hayashi S, Elliott WM, Xing L, Chan B, Yang L, Wright C, Sin D, Pare PD, Pierce JA, Pierce RA, Patterson A, Cooper J, Hogg JC: Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181:1329-1335.
33. Degen M, Goulet S, Ferralli J, Roth M, Tamm M, Chiquet-Ehrismann R: Opposite effect of fluticasone and salmeterol on fibronectin and tenascin-C expression in primary human lung fibroblasts. Clin Exp Allergy 2009, 39:688-699.
34. Harju T, Kinnula VL, Paakko P, Salmenkivi K, Risteli J, Kaarteenaho R: Variability in the precursor proteins of collagen I and III in different stages of COPD. Respir Res 2010, 11:165.
35. Lambert RK, Wiggs BR, Kuwano K, Hogg JC, Pare PD: Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol 1993, 74:2771-2781.
36. Lofdahl JM, Cederlund K, Nathell L, Eklund A, Skold CM: Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema. Eur Respir J 2005, 25:275-281.
37. Kaarteenaho-Wiik R, Kinnula VL, Herva R, Soini Y, Pollanen R, Paakko P: Tenascin-C is highly expressed in respiratory distress syndrome and bronchopulmonary dysplasia. J Histochem Cytochem 2002, 50:423-431.
38. Kaarteenaho-Wiik R, Paakko P, Sormunen R: Ultrastructural features of lung fibroblast differentiation into myofibroblasts. Ultrastruct Pathol 2009, 33:6-15.
39. Jeffery P, Holgate S, Wenzel S: Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment. Am J Respir Crit Care Med 2003, 168:S1-17.
40. Kaarteenaho-Wiik R, Tani T, Sormunen R, Soini Y, Virtanen I, Paakko P: Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am J Respir Crit Care Med 1996, 154:511-518.
41. Eyden B: Electron microscopy in the study of myofibroblastic lesions. Semin Diagn Pathol 2003, 20:13-24.
42. Michalik M, Pierzchalska M, Legutko A, Ura M, Ostaszewska A, Soja J, Sanak M: Asthmatic bronchial fibroblasts demonstrate enhanced potential to differentiate into myofibroblasts in culture. Med Sci Monit 2009, 15:BR194-201.
43. Miller M, Cho JY, McElwain K, McElwain S, Shim JY, Manni M, Baek JS, Broide DH: Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am J Physiol Lung Cell Mol Physiol 2006, 290:L162-169.
44. Hogg JC, Macklem PT, Thurlbeck WM: Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968, 278:1355-1360.